Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
BMP signaling agonist sb4
Cat. No.:
OB0225LY-0199
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
BMP signaling agonist sb4 is a small molecule agonist that activates the BMP signaling pathway, thereby affecting the process of cell proliferation and differentiation.
Synonym:
SB 4; 100874-08-6; 2-((4-Bromobenzyl)thio)benzo[d]oxazole; 2-(4-Bromobenzylsulfanyl)benzoxazole; 2-[[(4-Bromophenyl)methyl]thio]benzoxazole; 2-[(4-Bromophenyl)methylsulfanyl]-1,3-benzoxazole
CAS No.:
100874-08-6
Compound CID:
731364
Formula:
C14H10BrNOS
Formula Weight:
320.2
Specification
Relative Density:
1.57 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
BMP signaling agonist sb4 can be used to study the mechanisms of bone formation or play an important role in stem cell induced differentiation studies.
Library Information
Targets:
TGF-beta/Smad
Receptors:
Bone morphogenetic protein (BMP); TGF-β receptor
Pathways:
Stem cells
Plate Number:
AOCL-3
Plate Location:
e3
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
10 mg/mL; 31.23 mM
